Commentary: Dissecting the US FDA's Coartem approval
23 April 2009
Sue Sutter
With US approval of its antimalarial Coartem (artemether plus lumefantrine) earlier this month,
Novartis became the first pharmaceutical company to win a coveted priority review voucher from the
FDA.
Yet the approval was not as swift and clean as some might have expected for a drug that has long...
Please Login to read the full article.
23 April 2009
Sue Sutter
Yet the approval was not as swift and clean as some might have expected for a drug that has long...
Please Login to read the full article.
RELATED CONTENT
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
